tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

LRMR Stock Latest News

FDA selects Larimar for participation in START program for nomlabofusp in FA
The FlyFDA selects Larimar for participation in START program for nomlabofusp in FA
2M ago
LRMR
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
PremiumPress Releases
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
2M ago
LRMR
Larimar Therapeutics price target raised to $14 from $10 at Citi
PremiumThe Fly
Larimar Therapeutics price target raised to $14 from $10 at Citi
2M ago
LRMR
Larimar clinical hold lift ‘very positive for the stock,’ says Leerink
PremiumThe Fly
Larimar clinical hold lift ‘very positive for the stock,’ says Leerink
2M ago
LRMR
Larimar clinical hold removal ‘nice surprise,’ says William Blair
PremiumThe Fly
Larimar clinical hold removal ‘nice surprise,’ says William Blair
2M ago
LRMR
FDA removes hold on Larimar ‘s nomlabofusp program for FA
PremiumThe FlyFDA removes hold on Larimar ‘s nomlabofusp program for FA
2M ago
LRMR
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
PremiumPress Releases
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
2M ago
LRMR
Larimar Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Larimar Therapeutics files $300M mixed securities shelf
2M ago
LRMR
Larimar Therapeutics reports Q1 EPS (27c), consensus (23c)
PremiumThe Fly
Larimar Therapeutics reports Q1 EPS (27c), consensus (23c)
2M ago
LRMR
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
PremiumPress Releases
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
2M ago
LRMR
Leerink bullish on Larimar Therapeutics, initiates with an Outperform
PremiumThe Fly
Leerink bullish on Larimar Therapeutics, initiates with an Outperform
4M ago
LRMR
Larimar Therapeutics initiated with an Outperform at Leerink
PremiumThe Fly
Larimar Therapeutics initiated with an Outperform at Leerink
4M ago
LRMR
5 Stocks that Analysts Love in March 2024
PremiumMarket News5 Stocks that Analysts Love in March 2024
4M ago
GSK
ANAB
Larimar Therapeutics provides update on nomlabofusp development
PremiumThe Fly
Larimar Therapeutics provides update on nomlabofusp development
4M ago
LRMR
Larimar Therapeutics reports Q4 EPS (30c), consensus (25c)
PremiumThe Fly
Larimar Therapeutics reports Q4 EPS (30c), consensus (25c)
4M ago
LRMR
Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development
PremiumPress Releases
Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development
4M ago
LRMR
3 Best Stocks to Buy Now, 3/12/2024, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 3/12/2024, According to Top Analysts
4M ago
CRWD
LRMR
Larimar Therapeutics doses first patient in nomlabofusp study
PremiumThe Fly
Larimar Therapeutics doses first patient in nomlabofusp study
4M ago
LRMR
Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia
PremiumPress Releases
Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia
4M ago
LRMR
Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference
PremiumPress ReleasesLarimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference
5M ago
LRMR
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
5M ago
FAZ
SQM
Larimar Therapeutics, Inc. (LRMR) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Larimar Therapeutics, Inc. (LRMR) Q4 Earnings Cheat Sheet
5M ago
LRMR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >